司库奇尤单抗可能是治疗化脓性汗腺炎继发系统性淀粉样变的方法。
Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.
机构信息
University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Dermatology Clinic, Ankara, Turkey.
University of Health Sciences, Dr. Sami Ulus Obstetrics and Gynecology, Pediatric Health and Disease Training and Research Hospital, Ankara, Turkey.
出版信息
Dermatol Ther. 2020 Nov;33(6):e14205. doi: 10.1111/dth.14205. Epub 2020 Sep 11.
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.
化脓性汗腺炎（HS）是一种慢性复发性毛囊上皮炎症性疾病；许多合并症发生，扰乱了患者的生活质量。淀粉样变性就是其中之一。我们报告了一例继发于 HS 的系统性淀粉样变性病例，对司库奇尤单抗治疗有良好反应。司库奇尤单抗也可能是 HS 患者淀粉样变性发现的重要选择。
Zotero 插件